NEW YORK (Reuters) - Pfizer Inc <PFE.N> is set to present a nearly $4 billion offer for German generic-drug maker Ratiopharm GmbH this week, competing against rival bids from Teva Pharmaceutical Industries Ltd <TEVA.TA> and Actavis, sources familiar with the situation said on Tuesday. Pfizer had previously cooled on Ratiopharm, but was asked to rejoin ...

Pfizer Inc. said Thursday that William Ringo will retire as a senior vice president at the drug maker. Ringo will be replaced April 30 by Kristin Peck, who will become senior vice president of worldwide business development, strategy and innovation. Ringo has held that ...

Pfizer said Wednesday the Food and Drug Administration has approved an updated version of its best-selling infection vaccine for infants and children. Prevnar 13 is intended to reduce the risk of infection by 13 strains of pneumococcal disease in children 5 years old and younger. The disease causes ear infections, meningitis and pneumonia. Prevnar 13 adds protection against six additional ...

PREVNAR 13 APPROVED: The Food and Drug Administration on Wednesday approved a new version of Pfizer's best-selling vaccine Prevnar, which protects against pneumococcal disease. ADDED PROTECTION: Prevnar 13 adds protection against six additional strains of bacterial infection compared with the current vaccine. FDA approved the vaccine for children as young as six weeks old. VACCINE MONEYMAKER: Prevnar was the ...